UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 8, 2006
------------------
PETMED EXPRESS, INC.
-------------------------------------------------------
(Exact name of registrant as specified in its charter)
Florida 000-28827 65-0680967
------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
1441 S.W. 29th Avenue, Pompano Beach, Florida 33069
------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (954) 979-5995
----------------
-------------------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
[ ] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-
2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-
4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 Regulation FD Disclosure
Item 8.01 Other Events
On November 8, 2006, PetMed Express, Inc. issued a press
release announcing that the Board of Directors of PetMed Express,
Inc. has approved a share repurchase program of up to $20
million, effective immediately. This program is intended to be
implemented through purchases made from time to time in either
the open market or through private transactions at the Company's
discretion, subject to market conditions and other factors, in
accordance with Securities and Exchange Commission requirements.
There can be no assurances as to the precise number of shares
that will be repurchased under the share repurchase program, and
the Company may discontinue the share repurchase program at any
time subject to compliance with applicable regulatory
requirements. Shares purchased pursuant to the share repurchase
program will either be cancelled or held in the Company's
treasury. A copy of the press release is attached hereto as
Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits
99.1 Press release issued by PetMed Express, Inc. on
November 8, 2006
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.
PETMED EXPRESS, INC.
Date: November 8, 2006 By:/s/ Menderes Akdag
-----------------------------
Menderes Akdag,
Chief Executive Officer and President
By:/s/ Bruce S. Rosenbloom
------------------------------
Bruce S. Rosenbloom,
Chief Financial Officer
EXHIBIT INDEX
Exhibit No. Description
99.1 Press release issued by PetMed Express, Inc. on November 8, 2006